Clear Harbor Asset Management, LLC Moderna, Inc. Transaction History

Clear Harbor Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $19,037 - $25,743	223 Added 8.18%	2,948 $314,000
Q3 2023 Oct 26, 2023	BUY	$96.41 - $126.61 $262,717 - $345,012	2,725 New	2,725 $281,000
Q4 2022 Jan 20, 2023	BUY	$118.38 - $210.04 $133,177 - $236,295	1,125 New	1,125 $0
Q2 2022 Jul 20, 2022	SELL	$117.13 - $176.59 $138,799 - $209,259	-1,185 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$225.82 - $368.51 $5,645 - $9,212	25 Added 2.16%	1,185 $301,000
Q3 2021 Nov 03, 2021	SELL	$221.9 - $484.47 $6,657 - $14,534	-30 Reduced 2.52%	1,160 $446,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $154,592 - $279,626	1,190 New	1,190 $280,000
Q4 2020 Feb 04, 2021	SELL	$65.74 - $169.86 $79,874 - $206,379	-1,215 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$54.34 - $94.85 $66,023 - $115,242	1,215 New	1,215 $85,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.